Healthcare & Life Sciences
IgGenix
United Statesiggenix.com
IgGenix is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
3
Investors
About IgGenix
Based in the United States, IgGenix is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
IgGenix is a biotechnology company that discovers and engineers allergen-specific antibodies to block and prevent allergic reactions, aiming to treat pediatric and adult patients with severe allergies.
Explore IgGenix's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.